Y. Lim, Kyung-Hee Kim, Yung Zoon Jung, Sae-rom Choi, C. Song, Jun Nyun Kim
{"title":"Satisfaction Survey of the Regional Networks for Blood Transfusion Management Project","authors":"Y. Lim, Kyung-Hee Kim, Yung Zoon Jung, Sae-rom Choi, C. Song, Jun Nyun Kim","doi":"10.17945/kjbt.2020.31.1.34","DOIUrl":"https://doi.org/10.17945/kjbt.2020.31.1.34","url":null,"abstract":"Young Ae Lim, M.D., Kyung-Hee Kim, M.D., Yung Zoon Jung, M.D., Sae-Rom Choi, M.S., Chie Eun Song, M.S., Jun Nyun Kim, M.D. Department of Laboratory Medicine, Ajou University School of Medicine, Suwon; Department of Laboratory Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon; Department of Laboratory Medicine, Nasaret International Hospital, Incheon; Division of Blood Safety Surveillance, Korea Centers for Disease Control and Prevention, Cheongju, Korea","PeriodicalId":231122,"journal":{"name":"The Korean Journal of Blood Transfusion","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116823924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. Roh, Hyun Mi Kim, Jun Nyun Kim, Sinyoung Kim, H. Kim
{"title":"Practical Considerations in Convalescent Plasma Therapy for Coronavirus Disease 2019","authors":"J. Roh, Hyun Mi Kim, Jun Nyun Kim, Sinyoung Kim, H. Kim","doi":"10.17945/kjbt.2020.31.1.67","DOIUrl":"https://doi.org/10.17945/kjbt.2020.31.1.67","url":null,"abstract":"Convalescent plasma therapy has been used to achieve passive immunization against diverse infectious agents by administering pathogen-specific antibodies Coronavirus disease 19 (COVID-19), which originated in Wuhan, China, has recently become a major concern all over the world There are no specific treatment recommendations for COVID-19 because of the lack of knowledge and evidence about this virus Convalescent plasma therapy can be used as an empirical and investigational treatment for COVID-19, and so we briefly describe the main issues related to convalescent plasma therapy from the perspective of transfusion medicine","PeriodicalId":231122,"journal":{"name":"The Korean Journal of Blood Transfusion","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124907643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"COVID-19 and Transfusion Blood","authors":"M. Kim","doi":"10.17945/kjbt.2020.31.1.61","DOIUrl":"https://doi.org/10.17945/kjbt.2020.31.1.61","url":null,"abstract":"WHO declared that Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was pandemic on March 11, 2020 There have been 209,839 confirmed cases with 8,778 deaths and 4 2% fatality in the entire world up until March 19, 2020 The Korean Center for Diseases Prevention and Control (KCDC) announced that although 13 asymptomatic carriers of COVID-19 donated their blood in Korea, there was no evidence of SARS-CoV-2 in their donated blood There have been no worldwide reports of transfusion-transmitted infection with Coronavirus Specific measures for assessing COVID-19 were not yet required on blood collection and testing, except for the ban of blood donation during the quarantine due to the travel risk over the endemic area or the risk of confirmed cases or their close contactors Even the risk of blood safety associated with an infection may usually be milder than the risk of blood shortage during the endemic Thus, the assessment for COVID-19 in transfusion blood should continuously gain new evidence in Korea as well as throughout the world (Korean J Blood Transfus 2020;31:61-66)","PeriodicalId":231122,"journal":{"name":"The Korean Journal of Blood Transfusion","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129331388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Perioperative Management of Anemia Based on Patient Blood Management","authors":"J. Koh","doi":"10.17945/kjbt.2020.31.1.21","DOIUrl":"https://doi.org/10.17945/kjbt.2020.31.1.21","url":null,"abstract":"Perioperative anemia is common during surgery and is an important risk factor for the transfusion of RBC, morbidity and mortality. Blood transfusion has been a common practice for a long time, and has been a traditionally accepted solution to perioperative anemia. However, increasing evidence is now showing that this traditional treatment may actually do more harm than good. Research has shown that transfusion is independently associated with morbidity and mortality. A paradigm shift is currently taking place towards patient-oriented blood management and patient blood management, PBM. PBM consists of 3 pillars: the optimization of the red blood cell mass, reduction of blood loss and bleeding, and optimization of the patients’ physiological tolerance toward anemia. Of the three fillers, perioperative management is mainly included in the second pillar, but integration of these 3 pillars and strategies into perioperative pathways should improve care processes and patient outcome. Bleeding during surgery and efforts to stop it continue, and treatment for bleeding and many hemostatic methods have been developed. In recent decades, minimally invasive surgical techniques have led to a reduction of bleeding, where hemostatic agents, surgical instruments and new techniques have played an important role in the perioperative field of PBM. This paper summarized why PBM is needed, and the strategy during surgery simply and easily. This paper focuses on the surgeons’ role in PBM. The main PBM protocol is not discussed, but rather the paper focuses on selective clinical practice. (Korean","PeriodicalId":231122,"journal":{"name":"The Korean Journal of Blood Transfusion","volume":"15 10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132592573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hyein Kang, Do-Hoon Kim, D. Jeon, Wonmok Lee, N. Ryoo, J. Ha
{"title":"Two Cases of Successful Plasma Exchange with Unfractionated Heparin Anticoagulation in Patients Exhibiting Anaphylaxis to Acid-citrate-dextrose Formula A","authors":"Hyein Kang, Do-Hoon Kim, D. Jeon, Wonmok Lee, N. Ryoo, J. Ha","doi":"10.17945/kjbt.2020.31.1.55","DOIUrl":"https://doi.org/10.17945/kjbt.2020.31.1.55","url":null,"abstract":"Plasma exchange performed with the aid of acid-citrate-dextrose formula A (ACD-A) is generally regarded as safe. However, unfractionated heparin (UFH) can serve as an anticoagulant for patients experiencing serious side effects such as anaphylaxis. No guidelines have currently been defined for the stand-alone UFH dosing during plasma exchange. We describe here two patients who developed anaphylaxis to ACD-A during plasma exchange, and we successfully used UFH as a standalone anticoagulant. The first patient was a 55-year-old man who required plasma exchange before ABO-incompatible kidney transplantation. During plasma exchange, he developed an allergic reaction. Thereafter, UFH was used as a standalone anticoagulant during four sessions of plasma exchange; the UFH (5,000 units) was added to a 500 mL normal saline bag and the UFH:whole blood ratio was maintained at 1:28. The second patient was an 80-year-old woman with steroid pulse-resistant neuromyelitis optica. She developed an allergic reaction during the first session of plasma exchange. The patient subsequently underwent five successful sessions of plasma exchange using UFH as a standalone anticoagulant. These findings may be useful when establishing a protocol for UFH as a standalone anticoagulant during plasma exchange in patients who develop an allergic reaction to citrate. (Korean J Blood Transfus 2020;31:55-60)","PeriodicalId":231122,"journal":{"name":"The Korean Journal of Blood Transfusion","volume":"2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122946904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Namsu Kim, HongBi Yu, Jaehyeon Lee, D. Kim, Hye Soo Lee, Yoo Na Chung, Y. Cho, D. Cho
{"title":"ABO*B3.01 Found in the A1B3 Phenotype Showing ABO Discrepancy: The First Case in Korea","authors":"Namsu Kim, HongBi Yu, Jaehyeon Lee, D. Kim, Hye Soo Lee, Yoo Na Chung, Y. Cho, D. Cho","doi":"10.17945/kjbt.2019.30.3.236","DOIUrl":"https://doi.org/10.17945/kjbt.2019.30.3.236","url":null,"abstract":"ABO*B3.01 Found in the A1B3 Phenotype Showing ABO Discrepancy: The First Case in Korea Namsu Kim, HongBi Yu, Jaehyeon Lee, Dal Sik Kim, Hye Soo Lee, Yoo Na Chung, Yong Gon Cho, Duck Cho Department of Laboratory Medicine, Jeonbuk National University Medical School, Jeonju, Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea","PeriodicalId":231122,"journal":{"name":"The Korean Journal of Blood Transfusion","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121177759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kwang Seob Lee, Sinyoung Kim, J. Roh, S. Choi, Hyun Ok Kim
{"title":"Case Series of Transfusion-Related Acute Lung Injury in a Tertiary Hospital and a Practical Comparison with the New Diagnostic Criteria","authors":"Kwang Seob Lee, Sinyoung Kim, J. Roh, S. Choi, Hyun Ok Kim","doi":"10.17945/kjbt.2019.30.3.219","DOIUrl":"https://doi.org/10.17945/kjbt.2019.30.3.219","url":null,"abstract":"Background: Transfusion-related acute lung injury (TRALI) is defined as acute respiratory distress syndrome with non-cardiogenic pulmonary edema caused by transfusion. It occurs only rarely but could result in patient mortality. TRALI has been declining since the successful adoption of TRALI risk mitigation strategies in several countries. The new diagnostic criteria were suggested in 2019 based on the knowledge and experience gained throughout the last decade. This article integrated a series of TRALI cases diagnosed in a tertiary hospital while reviewing each case based upon the new diagnostic criteria. Methods: Among the reported transfusion adverse reactions that occurred from March 2013 to June 2019, seven TRALI cases were recruited for this study. Each case was retrospectively reexamined with its clinical condition and transfusion history. The diagnosed cases were classified into TRALI subtypes newly suggested in the 2019 version. Results: The mean time interval to adverse reaction was 117 minutes (range: 7~370 minutes) and all satisfied the condition of hypoxemia and bilateral pulmonary infiltrations. The transfused blood components were apheresis platelets in three cases, platelet concentrates in one case, red blood cells in one case and combinations of different products in two cases. Five cases were diagnosed as possible TRALI, and all five cases were diagnosed as TRALI type 2 (2019 criteria). Conclusion: In our center, seven patients were diagnosed TRALI during the last 6 years. Screening more TRALI patients according to the new criteria, along with investigating the patients’ clinical characteristics, transfused blood components, treatments and integrated research, will facilitate Korean research on this field of medicine. (Korean J Blood Transfus 2019;30:219-229) acute lung injury; ARDS, acute respiratory distress syndrome; LAH, left atrial hypertension.","PeriodicalId":231122,"journal":{"name":"The Korean Journal of Blood Transfusion","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121621419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Distribution of Hemoglobin Concentration before Transfusion for Evaluation of Appropriateness of Red Blood Cell Transfusion","authors":"In-Hwa Jeong, K. Kim, Gyu-Dae An, Gi-Cheol Jeong","doi":"10.17945/kjbt.2019.30.3.230","DOIUrl":"https://doi.org/10.17945/kjbt.2019.30.3.230","url":null,"abstract":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright C2019 The Korean Society of Blood Transfusion 적혈구 제제의 수혈 적정성 평가를 위한 수혈 전 혈색소 농도 분포 조사","PeriodicalId":231122,"journal":{"name":"The Korean Journal of Blood Transfusion","volume":"59 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131608999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sunmi Shin, J. Kang, Jungwon Kang, Y. I. Seo, J. Park, Dae Dong Lee, H. Min, Myunghan Kim
{"title":"Analysis of HCV RNA Genotypes and Quantitative Values of Korean HCV NAT Reactive Blood Donors","authors":"Sunmi Shin, J. Kang, Jungwon Kang, Y. I. Seo, J. Park, Dae Dong Lee, H. Min, Myunghan Kim","doi":"10.17945/kjbt.2019.30.3.205","DOIUrl":"https://doi.org/10.17945/kjbt.2019.30.3.205","url":null,"abstract":"Sunmi Shin, Jae-won Kang, Jungwon Kang, Young Ik Seo, Jung Ran Park, Dae Dong Lee, Hyukki Min, Myunghan Kim Central Blood Laboratory Center, Korean Red Cross/Quality Management Team, Seoul, Blood Transfusion Research Institute, Korean Red Cross/TTI Research Team, Wonju, Central Blood Laboratory Center, Korean Red Cross, Seoul, Daejeon Sejong Chungnam Blood Center, Korean Red Cross, Busan, Nambu Blood Laboratory Center, Korean Red Cross, Jungbu Blood Laboratory Center, Korean Red Cross, Daejeon, Korea","PeriodicalId":231122,"journal":{"name":"The Korean Journal of Blood Transfusion","volume":"84 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128367084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jin-Woo Souk, Yang-Ki Kim, Gae-Eil Jang, Hyun-Seok Jeong, S. Uh, Ki-Up Kim, S. Koo, B. Lee, Hyunjin Noh, W. Shin, J. Shin, S. Jin
{"title":"Rifampin-Induced Immune Hemolytic Anemia during Treatment of Pulmonary Tuberculosis in a Patient with Primary Sjogren's Syndrome","authors":"Jin-Woo Souk, Yang-Ki Kim, Gae-Eil Jang, Hyun-Seok Jeong, S. Uh, Ki-Up Kim, S. Koo, B. Lee, Hyunjin Noh, W. Shin, J. Shin, S. Jin","doi":"10.17945/kjbt.2019.30.3.246","DOIUrl":"https://doi.org/10.17945/kjbt.2019.30.3.246","url":null,"abstract":"","PeriodicalId":231122,"journal":{"name":"The Korean Journal of Blood Transfusion","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115116687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}